Main Street Compounding Pharmacy Recalls Compounded Testosterone Due to Adverse Reactions
Main Street Family Pharmacy is recalling compounded Testosterone 200mg 30ml vials after receiving reports of skin abscesses linked to a related compounded product.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves reports of skin abscesses, which constitute significant injury reports, meeting the criteria for a Severe (4) rating.
Plain-English summary
Main Street Family Pharmacy, LLC is recalling 4 units of compounded Testosterone 200mg 30ml. The recall was initiated after the firm received seven reports of adverse reactions in the form of skin abscesses. These reactions were potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
The affected product was distributed nationwide, including in AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV. The product was distributed prior to and including May 23, 2013.
Consumers who have this product should stop using it and contact Main Street Compounding Pharmacy at 888-658-6200 for instructions on how to return the product.
The recalled product
- Product
- Testosterone 200mg 30ml (compounded), Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200
- Manufacturer
- Main Street Family Pharmacy, LLC
- Category
- Drug — Compounded Prescription
- Hazard
- Affected units
- 4
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- distributed prior to and including 05/23/2013
Distribution
Part of a larger recall action
This product is one of 299 recalled by Main Street Family Pharmacy, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 299 products in this recall →Related recalls
Same manufacturer · Main Street Family Pharmacy, LLC
See all →- SevereMain Street Compounding Pharmacy Recalls Acetylcystein 10% Vials
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Minoxidil 10% Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls HCG 11000u w/B-12
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Brompheniramine Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Methylcobalamin Due to Adverse Reaction Reports
FDA (Drugs) · 2013-12-11
Same hazard · skin abscess
See all →- SevereMain Street Compounding Pharmacy Recalls Lipotropic 10ml with B-12 and L-Carnitine
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Testosterone Pellets Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Dexamethasone LA Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
Similar recalls
- SevereCompounded Testosterone and Estradiol Injection Recalled for Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Propionate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- High
- SevereUS Compounding Recalls Testosterone Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25